Cara Therapeutics, Inc. (CARA) Doses First Patient in Phase 1 Study of Oral CR845

Cara Therapeutics Doses First Patient in Phase 1 Study of Oral CR845 in Non-Hemodialysis Chronic Kidney Disease Patients Cara Therapeutics, Inc. (CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus and pain by selectively targeting peripheral kappa opioid receptors, today announced that it has dosed the first patient
Complete Reading

American Medical Marijuana Physicians Association Endorses Alternate Health’s CanaPass Patient Management System   Toronto, ON, September 25, 2017 – Alternate Health Corp (“Alternate Health” or the “Company”) (CSE:AHG) (OTC:AHGIF), an international medical cannabis company that uses best-in-class technology, research, education, production and laboratories to increase the awareness, regulatory compliance, and appropriate usage of cannabinoids in
Complete Reading

PRESS RELEASE|Chart | Calendar   | TRADE NOW | CANNABIS New Colombia Resources Inc. Reports Sannabis has Successfully Treated Another Prostate Cancer Patient with their Pure Cannabis Extracts BUZ INVESTORS  NEWC Reports Sannabis New Colombia Resources, Inc. (“the Company”) ( OTC PINK : (NEWC), a Colombian natural resource company listed in the U.S., with premium metallurgical coal and
Complete Reading

 PUBLIC SERVICES, IMPROVE PATIENT CARE Buz Investors  PUBLIC SERVICES, IMPROVE PATIENT CARE  The Manitoba government is introducing companion pieces of legislation to protect the front-line services relied upon by Manitoba families, deliver better patient care through necessary reform and bargaining unit restructuring, and guard against tax increases, Finance Minister Cameron Friesen and Health, Seniors and
Complete Reading

Create Account



Log In Your Account